Semnur Pharmaceuticals, Inc.

Semnur Pharmaceuticals, Inc. financial statements

Semnur Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

Net income−USD 160.42M10-K
Cash and equivalentsUSD 20K10-Q

Semnur Pharmaceuticals, Inc. financials on 6ix · Semnur Pharmaceuticals, Inc. on 6ix